Evaluation of critical formulation parameters in design and differentiation of self-microemulsifying drug delivery systems (SMEDDSs) for oral delivery of aciclovir
The study investigated the influence of formulation parameters for design of self-microemulsifying drug delivery systems (SMEDDSs) comprising oil (medium chain triglycerides) (10%), surfactant (Labrasol(®), polysorbate 20, or Kolliphor(®) RH40), cosurfactant (Plurol(®) Oleique CC 497) (q.s. ad 100%), and cosolvent (glycerol or macrogol 400) (20% or 30%), and evaluate their potential as carriers for oral delivery of a poorly permeable antivirotic aciclovir (acyclovir). The drug loading capacity of the prepared formulations ranged from 0.18-31.66mg/ml. Among a total of 60 formulations, three formulations meet the limits for average droplet size (Z-ave) and polydispersity index (PdI) that have been set for SMEDDSs (Z-ave≤100nm, PdI<0.250) upon spontaneous dispersion in 0.1M HCl and phosphate buffer pH 7.2. SMEDDSs with the highest aciclovir loading capacity (24.06mg/ml and 21.12mg/ml) provided the in vitro drug release rates of 0.325mgcm(-2)min(-1) and 0.323mgcm(-2)min(-1), respectively, and significantly enhanced drug permeability in the parallel artificial membrane permeability assay (PAMPA), in comparison with the pure drug substance. The results revealed that development of SMEDDSs with enhanced drug loading capacity and oral delivery potential, required optimization of hydrophilic ingredients, in terms of size of hydrophilic moiety of the surfactant, surfactant-to-cosurfactant mass ratio (Km), and log P of the cosolvent..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:497 |
---|---|
Enthalten in: |
International journal of pharmaceutics - 497(2016), 1-2, Seite 301-311 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Janković, Jovana [VerfasserIn] |
---|
Links: |
---|
BKL: |
---|
doi: |
10.1016/j.ijpharm.2015.11.011 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC1965985912 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1965985912 | ||
003 | DE-627 | ||
005 | 20220222075852.0 | ||
007 | tu | ||
008 | 160206s2016 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijpharm.2015.11.011 |2 doi | |
028 | 5 | 2 | |a PQ20160430 |
035 | |a (DE-627)OLC1965985912 | ||
035 | |a (DE-599)GBVOLC1965985912 | ||
035 | |a (PRQ)c932-87076bb25bd31047b64f1efec2662c90c1b94908c7d5cd2c11dffc4d019f2a2e0 | ||
035 | |a (KEY)0052117520160000497000100301evaluationofcriticalformulationparametersindesigna | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DNB |
084 | |a PHARM |2 fid | ||
084 | |a 44.40 |2 bkl | ||
100 | 1 | |a Janković, Jovana |e verfasserin |4 aut | |
245 | 1 | 0 | |a Evaluation of critical formulation parameters in design and differentiation of self-microemulsifying drug delivery systems (SMEDDSs) for oral delivery of aciclovir |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a The study investigated the influence of formulation parameters for design of self-microemulsifying drug delivery systems (SMEDDSs) comprising oil (medium chain triglycerides) (10%), surfactant (Labrasol(®), polysorbate 20, or Kolliphor(®) RH40), cosurfactant (Plurol(®) Oleique CC 497) (q.s. ad 100%), and cosolvent (glycerol or macrogol 400) (20% or 30%), and evaluate their potential as carriers for oral delivery of a poorly permeable antivirotic aciclovir (acyclovir). The drug loading capacity of the prepared formulations ranged from 0.18-31.66mg/ml. Among a total of 60 formulations, three formulations meet the limits for average droplet size (Z-ave) and polydispersity index (PdI) that have been set for SMEDDSs (Z-ave≤100nm, PdI<0.250) upon spontaneous dispersion in 0.1M HCl and phosphate buffer pH 7.2. SMEDDSs with the highest aciclovir loading capacity (24.06mg/ml and 21.12mg/ml) provided the in vitro drug release rates of 0.325mgcm(-2)min(-1) and 0.323mgcm(-2)min(-1), respectively, and significantly enhanced drug permeability in the parallel artificial membrane permeability assay (PAMPA), in comparison with the pure drug substance. The results revealed that development of SMEDDSs with enhanced drug loading capacity and oral delivery potential, required optimization of hydrophilic ingredients, in terms of size of hydrophilic moiety of the surfactant, surfactant-to-cosurfactant mass ratio (Km), and log P of the cosolvent. | ||
540 | |a Nutzungsrecht: Copyright © 2015 Elsevier B.V. All rights reserved. | ||
700 | 1 | |a Djekic, Ljiljana |4 oth | |
700 | 1 | |a Dobričić, Vladimir |4 oth | |
700 | 1 | |a Primorac, Marija |4 oth | |
773 | 0 | 8 | |i Enthalten in |t International journal of pharmaceutics |d Amsterdam : Elsevier [u.a.], 1978 |g 497(2016), 1-2, Seite 301-311 |w (DE-627)130037605 |w (DE-600)428962-6 |w (DE-576)015579328 |x 0378-5173 |7 nnns |
773 | 1 | 8 | |g volume:497 |g year:2016 |g number:1-2 |g pages:301-311 |
856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.ijpharm.2015.11.011 |3 Volltext |
856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26611669 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
936 | b | k | |a 44.40 |q AVZ |
951 | |a AR | ||
952 | |d 497 |j 2016 |e 1-2 |h 301-311 |